Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapy. Found 488 abstracts

no pagination
Langer CJ. The emerging role of paclitaxel and carboplatin in non-small cell lung carcinoma. In: Updates in Advances in Lung Cancer. 1997. p. 73-90.
Lattanzi JP, Hanlon AL, Hanks GE. Early stage prostate cancer treated with radiation therapy: Stratifying an intermediate risk group. International Journal of Radiation Oncology Biology Physics. 1997 Jun;38(3):569-73.
Lawton CA, Winter K, Byhardt R, Sause WT, Hanks GE, Russell AH, Rotman M, Porter A, McGowan DG, DelRowe JD, Pilepich MV. Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). International Journal of Radiation Oncology Biology Physics. 1997 Jul 15;38(5):931-9.
Le Fur N, Kelsall SR, Silvers WK, Mintz B. Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: a projected basis for immunotherapy. Proc Natl Acad Sci U S A. 1997 May 13;94(10):5332-7.
Le Fur N, Silvers WK, Kelsall SR, Mintz B. Up-regulation of specific tyrosinase mRNAs in mouse melanomas with the c2j gene substituted for the wild-type tyrosinase allele: utilization in design of syngeneic immunotherapy models. Proc Natl Acad Sci U S A. 1997 Jul 08;94(14):7561-5.
McGee KP, Fein DA, Hanlon AL, Schultheiss TE, Fowble BL. The value of setup portal films as an estimate of a patient's position throughout fractionated tangential breast irradiation: An on-line study. International Journal of Radiation Oncology Biology Physics. 1997 Jan;37(1):223-8.
Ozols RF. Controversies in the management of ovarian cancer. International Journal of Gynecological Cancer. 1997 May;7:27-32.
Ozols RF. Update of the NCCN ovarian cancer practice guidelines. Oncology (Huntingt). 1997 Nov;11(11A):95-105.
Schneider RF, Engelhardt EL, Stobbe CC, Fenning MC, Chapman JD. The synthesis and radiolabeling of novel markers of tissue hypoxia of the iodinated azomycin nucleoside class. Journal of Labelled Compounds & Radiopharmaceuticals. 1997 Jul;39(7):541-57.
Weiner LM. Biological therapies for gastrointestinal cancers. Curr Opin Oncol. 1997 Jul;9(4):373-9.
Chang A, Yeap B, Davis T, Blum R, Hahn R, Khanna O, Fisher H, Rosenthal J, Witte R, Schinella R, Trump D. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: Flutamide versus diethylstilbestrol. Journal of Clinical Oncology. 1996 Aug;14(8):2250-7.
Chapman JD, Coia LR, Stobbe CC, Engelhardt EL, Fenning MC, Schneider RF. Prediction of tumour hypoxia and radioresistance with nuclear medicine markers. British Journal of Cancer. 1996 Jul;74:S204-S208.
Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. Journal of Clinical Oncology. 1996 Sep;14(9):2527-39.
Fowble B, Fein DA, Hanlon AL, Eisenberg BL, Hoffman JP, Sigurdson ER, Daly MB, Goldstein LJ. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. International Journal of Radiation Oncology Biology Physics. 1996 Jul;35(4):669-77.
Freedman GM, Hanlon AL, Lee WR, Hanks GE. Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation. International Journal of Radiation Oncology Biology Physics. 1996 May;35(2):243-50.
Hanks GE. Long-term control of prostate cancer with radiation - Past, present, and future. Urologic Clinics of North America. 1996 Nov;23(4):605-&.
Kutcher GJ, Smith AR, Fowble BL, Owen JB, Hanlon A, Wallace M, Hanks GE. Treatment planning for primary breast cancer: A patterns of care study. International Journal of Radiation Oncology Biology Physics. 1996 Oct;36(3):731-7.
Urtasun RC, Paliament MB, McEwan AJ, Mercer JR, Mannan RH, Wiebe LI, Morin C, Chapman JD. Measurement of hypoxia in human tumours by non-invasive SPECT imaging of iodoazomycin arabinoside. British Journal of Cancer. 1996 Jul;74:S209-S212.
Algan O, Coia LR, Keller SM, Engstrom PF, Weiner LM, Schultheiss TE, Hanks GE. Management of Adenocarcinoma of the Esophagus with Chemoradiation Alone or Chemoradiation Followed by Esophagectomy - Results of Sequential Nonrandomized Phase-Ii Studies. International Journal of Radiation Oncology Biology Physics. 1995 Jun 15;32(3):753-61.
Algan O, Hanks GE, Shaer AH. Localization of the Prostatic Apex for Radiation Treatment Planning. International Journal of Radiation Oncology Biology Physics. 1995 Nov;33(4):925-30.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapy

therapy cancer carcinoma chemotherapy radical prostatectomy antigen survival iodoazomycin arabinoside Immunotherapy Messenger RNA oxygen randomized trial Animal Human Monophenol Monooxygenase radiation- genetics Clinical Trials irradiation Mice Experimental Melanoma breast morbidity radiotherapy prostate carcinoma US Gov't Support-PHS Non-US Gov't Support treatment planning cells prostate-specific antigen Transgenic Mice squamous-cell carcinoma Skin conservative surgery tamoxifen rtog analysis phase-iii Neoplasm Metastasis patterns of care adenocarcinoma of the esophagus Inbred C57BL Mice phase-ii intensity setup reproducibility prognosis Female human-tumors cyproterone-acetate Ovarian Neoplasms quality assurance adenocarcinoma of the prostate conservative surgery and radiation and esophagectomy Alleles clinical use azomycin nucleosides Up-Regulation taxol plus carboplatin hormonal treatment Variation (Genetics) combined chemotherapy experience bioreductive drug carboplatin hypoxia Inbred Strains Mice adenocarcinoma Alternative Splicing Skin Neoplasms antiandrogens Radioimmunotherapy patterns whole abdomen irradiation external-beam radiation prognostic factor apex young men prostate cancer nitroimidazole beta-D-iodoazomycin xylopyranoside tension measurements localization films cisplatin-cyclophosphamide pathology field placement errors EPID support internal mammary lymphoscintigraphy localization of the prostatic transhiatal esophagectomy hormonal medroxyprogesterone acetate 3-field technique imaging tumor oxygenation single photon emission isocentric technique mv x-rays radiation treatment Follow-Up Studies bioreducible drug hypoxic markers series accuracy biosynthesis adjuvant tamoxifen Simian virus 40 prognostic physiopathology paclitaxel-cisplatin cooperative-oncology-group Practice Guidelines pathological stage simulation anus recurrence paclitaxel Exons computerised tomography gynecologic-oncology-group immunology chemoradiation primary breast cancer hyperfractionated radiation- PSA nadir verification Polymerase Chain Reaction nonsteroidal antiandrogen cytoreductive surgery diagnosis enzymology study Genetic Transcription po2 cancer irradiation tumor fluoromisonidazole 3d conformal treatment planning new standard Gastrointestinal Neoplasms stage radiation oncology external-beam irradiation combined modality therapy preoperative chemotherapy misonidazole intraperitoneal chemotherapy management
Last updated on Wednesday, August 05, 2020